Truist downgraded Amgen to Hold from Buy with a $333 price target
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AMGN:
- RBC Capital remains bullish on Regeneron, continues to see buying opportunity
- Amgen price target raised to $315 from $300 at Barclays
- Piper Sandler biotech analysts hold an analyst/industry conference call
- Amgen partners with La La Anthony
- Wynn Resorts upgraded, HP Inc. downgraded: Wall Street’s top analyst calls